Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-22-013304
Filing Date
2022-11-08
Accepted
2022-11-08 18:00:18
Documents
2
Period of Report
2022-11-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57375.html 3  
1 PRIMARY DOCUMENT marketforms-57375.xml 3 1714
2 POA DOCUMENT poa.htm EX-24 3116
  Complete submission text file 0001214659-22-013304.txt   6179
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR PUDONG SHANGHAI F4 201210
Business Address
Sandler Alan B. (Reporting) CIK: 0001835966 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 221370186